New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Anti-PD-1 Antibody Pidilizumab Shows Promise in Diffuse Large B-Cell Lymphoma

Anti-PD-1 Antibody Pidilizumab Shows Promise in Diffuse Large B-Cell Lymphoma

January 17, 2014Tony Berberabe, MPHThe anti-PD-1 monoclonal antibody pidilizumab showed promising clinical activity and was safely administered to patients with diffuse large B-cell lymphoma after aut
World medicine November 21,2023
Anti-PD-1 Antibody Pidilizumab Shows Promise in Diffuse Large B-Cell Lymphoma

Anti-PD-1 Antibody Pidilizumab Shows Promise in Diffuse Large B-Cell Lymphoma

January 17, 2014Tony Berberabe, MPHThe anti-PD-1 monoclonal antibody pidilizumab showed promising clinical activity and was safely administered to patients with diffuse large B-cell lymphoma after aut
World medicine November 21,2023
Efforts Continue to Enhance Stem Cell Transplants

Efforts Continue to Enhance Stem Cell Transplants

March 1, 2018Angelica WelchCarlos R. Bachier, MD, discusses the evolution of stem cell transplantation as a treatment for patients with hematologic malignancies.Carlos R. Bachier, MDEven with recent s
World medicine November 21,2023
Efforts Continue to Enhance Stem Cell Transplants

Efforts Continue to Enhance Stem Cell Transplants

March 1, 2018Angelica WelchCarlos R. Bachier, MD, discusses the evolution of stem cell transplantation as a treatment for patients with hematologic malignancies.Carlos R. Bachier, MDEven with recent s
World medicine November 21,2023
Computer Model Personalizes Donor Selection for Stem Cell Transplants

Computer Model Personalizes Donor Selection for Stem Cell Transplants

August 31, 2016Amir Ahmed Toor, MDIn Partnership With:Investigators at Virginia Commonwealth University Massey Cancer Center are developing dynamical models that may allow clinicians to move beyond si
World medicine November 21,2023
Computer Model Personalizes Donor Selection for Stem Cell Transplants

Computer Model Personalizes Donor Selection for Stem Cell Transplants

August 31, 2016Amir Ahmed Toor, MDIn Partnership With:Investigators at Virginia Commonwealth University Massey Cancer Center are developing dynamical models that may allow clinicians to move beyond si
World medicine November 21,2023
Stem Cell Transplants in Hodgkin Lymphoma

Stem Cell Transplants in Hodgkin Lymphoma

January 21, 2015For High-Definition, ClickThe standard of care for an individual with Hodgkin lymphoma who fails induction chemotherapy is salvage chemotherapy followed by stem cell transplant, states
World medicine November 21,2023
Stem Cell Transplants in Hodgkin Lymphoma

Stem Cell Transplants in Hodgkin Lymphoma

January 21, 2015For High-Definition, ClickThe standard of care for an individual with Hodgkin lymphoma who fails induction chemotherapy is salvage chemotherapy followed by stem cell transplant, states
World medicine November 21,2023
Patient-Derived Cancer Stem Cells Offer Diagnostic and Therapeutic Potential in Brain Cancer

Patient-Derived Cancer Stem Cells Offer Diagnostic and Therapeutic Potential in Brain Cancer

March 1, 2017John S. Kuo, MD, PhD, FAANS, FACSA brain tumor research group at the UW Carbone Cancer Center focuses on biological studies of patient-derived glioblastoma multiforme (GBM) cancer stem ce
World medicine November 21,2023
Patient-Derived Cancer Stem Cells Offer Diagnostic and Therapeutic Potential in Brain Cancer

Patient-Derived Cancer Stem Cells Offer Diagnostic and Therapeutic Potential in Brain Cancer

March 1, 2017John S. Kuo, MD, PhD, FAANS, FACSA brain tumor research group at the UW Carbone Cancer Center focuses on biological studies of patient-derived glioblastoma multiforme (GBM) cancer stem ce
World medicine November 21,2023
No Age Limit for Bone Marrow Transplantation

No Age Limit for Bone Marrow Transplantation

October 10, 2013Rainer Storb, MDAge is no longer a consideration when determining whether an older patient with blood cancer is a candidate for stem cell transplantation.Rainer Storb, MDMember, Clinic
World medicine November 21,2023
No Age Limit for Bone Marrow Transplantation

No Age Limit for Bone Marrow Transplantation

October 10, 2013Rainer Storb, MDAge is no longer a consideration when determining whether an older patient with blood cancer is a candidate for stem cell transplantation.Rainer Storb, MDMember, Clinic
World medicine November 21,2023
Grant Aims to Deliver First Stem-Cell Immunotherapy in Ovarian Cancer

Grant Aims to Deliver First Stem-Cell Immunotherapy in Ovarian Cancer

January 19, 2015Christin MeltonThe New York State Stem Cell Science Program recently awarded a 4-year $11.9 million grant to Roswell Park Cancer Institute to fund research and development of a stem-ce
World medicine November 21,2023
Grant Aims to Deliver First Stem-Cell Immunotherapy in Ovarian Cancer

Grant Aims to Deliver First Stem-Cell Immunotherapy in Ovarian Cancer

January 19, 2015Christin MeltonThe New York State Stem Cell Science Program recently awarded a 4-year $11.9 million grant to Roswell Park Cancer Institute to fund research and development of a stem-ce
World medicine November 21,2023
Stem Cell Transplantation Feasible in Elderly Patients With Myeloma

Stem Cell Transplantation Feasible in Elderly Patients With Myeloma

September 6, 2018Jason HarrisAndrew L. Pecora, MD, discusses the use of autologous stem cell transplantation in patients aged ≥75 years and the future of care in multiple myeloma.Andrew L. Pecora, MD,
World medicine November 21,2023
Stem Cell Transplantation Feasible in Elderly Patients With Myeloma

Stem Cell Transplantation Feasible in Elderly Patients With Myeloma

September 6, 2018Jason HarrisAndrew L. Pecora, MD, discusses the use of autologous stem cell transplantation in patients aged ≥75 years and the future of care in multiple myeloma.Andrew L. Pecora, MD,
World medicine November 21,2023
Role of Stem Cell Transplantation Evolving in Multiple Myeloma

Role of Stem Cell Transplantation Evolving in Multiple Myeloma

March 11, 2015Laura PanjwaniOncLive interviewed Ravi Vij, MD, associate professor, Division of Oncology, Section of Bone Marrow Transplantation, Washington University School of Medicine and the Sitema
World medicine November 21,2023
Role of Stem Cell Transplantation Evolving in Multiple Myeloma

Role of Stem Cell Transplantation Evolving in Multiple Myeloma

March 11, 2015Laura PanjwaniOncLive interviewed Ravi Vij, MD, associate professor, Division of Oncology, Section of Bone Marrow Transplantation, Washington University School of Medicine and the Sitema
World medicine November 21,2023
Stem Cell Transplant Continues to Show Benefit in 'Novel-Agent Era' of Multiple Myeloma

Stem Cell Transplant Continues to Show Benefit in 'Novel-Agent Era' of Multiple Myeloma

May 18, 2016Laura PanjwaniEarly findings from a phase III clinical trial suggest that patients with multiple myeloma who receive upfront autologous stem cell transplant survive longer without disease
World medicine November 21,2023
Stem Cell Transplant Continues to Show Benefit in 'Novel-Agent Era' of Multiple Myeloma

Stem Cell Transplant Continues to Show Benefit in 'Novel-Agent Era' of Multiple Myeloma

May 18, 2016Laura PanjwaniEarly findings from a phase III clinical trial suggest that patients with multiple myeloma who receive upfront autologous stem cell transplant survive longer without disease
World medicine November 21,2023
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com